Harmonised relative effectiveness discussions moving ahead in Europe
This article was originally published in SRA
Executive Summary
Support for a single European relative effectiveness assessment conducted by the European Medicines Agency is gaining momentum with the pharmaceutical industry, said Andrew Witty, president of the European pharmaceutical industry federation, EFPIA, at a press conference for its annual meeting in London, 21-22 June1.